Last update Aug. 24, 2022
Very Low Risk
Polyethylene glycol or macrogol is an osmotic laxative that has minimal intestinal absorption. The little that can be absorbed is excreted unmetabolized in the urine. It is made of polymerss whose molecular weight is between 1,000 and 35,000 daltons. The number added to the term "macrogol" defines its molecular weight, eg: macrogol 3350. Oral administration. Another use is pegylation: it is the conjugation of drugs and therapeutic proteins with polyethylene glycol (PEG) to improve their pharmacokinetic profiles and reduce their adverse effects (see Nonacog Beta Pegol, pegaspargase, pegfilgrastim, peginterferon alfa, peginterferon beta, Rurioctocog Alfa Pegol)
It is not excreted in breast milk in detectable amount. (Clowse 2017)
Its pharmacokinetic data (almost zero oral bioavailability and high molecular weight) make it impossible to transfer significant quantities into breastmilk.
Its almost null oral bioavailability prevents its transfer to the infant’s plasma via ingested breast milk.
Experts and scientific associations, as well as the manufacturer, consider it compatible with breastfeeding. (LactMed, Gharehbaghi 2016, Briggs 2015, Müller 2013, AEMPS 2010, Mahadevan 2006)
We do not have alternatives for A06AD15 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM